Search clinical trials for: Ontak (Denileukin Diftitox)
Total 51 results
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Barbara Ann Karmanos Cancer InstituteEisai Inc.TerminatedMultiple MyelomaUnited States
-
Eisai Inc.No longer available
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-CellUnited States
-
Eisai Inc.CompletedLymphoma, B-CellUnited States
-
The University of Texas Health Science Center at...CompletedEpithelial Ovarian Cancer | Fallopian Tube Carcinoma | Extraovarian Peritoneal CancerUnited States
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
Loyola UniversityEisai Inc.; Riveria Country Club OrganizationTerminatedMetastatic Pancreatic CancerUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Systemic MastocytosisUnited States
-
The University of Texas Health Science Center at...TerminatedEpithelial Ovarian Cancer | Fallopian Tube Carcinoma | Extraovarian Peritoneal CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Pharmatech OncologyUnknownLymphoma | LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedKidney Cancer | Melanoma (Skin)United States
-
Columbia UniversityWithdrawn
-
Eisai Inc.PharmaBio Development Inc.CompletedStage IV Melanoma | Stage IIIC MelanomaUnited States
-
H. Kim LyerlyNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Eisai Inc.CompletedLymphoma, T-cell, Peripheral | Lymphoma, T-cell, CutaneousJapan
-
University Hospital ErlangenCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Ligand PharmaceuticalsCompletedLymphoma | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...WithdrawnCHRONIC LYMPHOCYTIC B-LEUKEMIA
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedGraft vs Host Disease | Immune System DisordersUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedHaploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)Leukemia, Myelogenous, AcuteUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Ovarian Germ Cell TumorUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Eisai Inc.CompletedLeukemia, Lymphocytic, ChronicCanada, Australia, United States, Argentina, Brazil
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, Australia, United Kingdom, Austria, Russian Federation, United States, Poland, Switzerland
-
Eisai Inc.CompletedNon-Hodgkin's Lymphoma | Lymphoma, B-cell | Lymphoma, Low-gradeUnited States
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
-
PharmaciaCompletedHIV Infections | Mycobacterium Avium-Intracellulare InfectionUnited States
-
Eisai Inc.CompletedLymphoma, T-Cell, PeripheralUnited States
-
University of ChicagoEisai Inc.Terminated
-
Yale UniversityEisai Inc.CompletedPeripheral T-Cell LymphomaUnited States
-
Boston Scientific CorporationCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
Boston Scientific CorporationCompleted
-
Guidant CorporationTerminated
-
Boston Scientific CorporationCompletedCongestive Heart FailureUnited States
-
Chromaderm, Inc.CompletedDiabetic RetinopathyUnited States
-
University of MiamiWithdrawn
-
Haider MahdiDr. Reddys Laboratories, SARecruitingEpithelial Ovarian CancerUnited States
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
Taro Pharmaceuticals USACompleted
-
Oregon State UniversityCompleted